Pyxis Oncology (PYXS) Earnings Date, Estimates & Call Transcripts → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free PYXS Stock Alerts $4.84 +0.15 (+3.20%) (As of 03:22 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 21) -$0.33 Beat By $0.16 Consensus EPS (Mar. 21) -$0.49 Get Pyxis Oncology Earnings AlertsEnter your email address below to receive the latest news and earnings results for PYXS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePYXS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PYXS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Market Insiders#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 Pyxis Oncology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.55)($0.24)($0.37)Q2 20243($0.52)($0.26)($0.36)Q3 20243($0.51)($0.19)($0.33)Q4 20243($0.52)($0.23)($0.34)FY 202412($2.10)($0.92)($1.40)Q1 20251($0.41)($0.41)($0.41)Q2 20251($0.26)($0.26)($0.26)Q3 20251($0.27)($0.27)($0.27)Q4 20251($0.29)($0.29)($0.29)FY 20254($1.23)($1.23)($1.23)PYXS Earnings Date and InformationPyxis Oncology last issued its earnings data on March 21st, 2024. The reported ($0.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.49) by $0.16. Pyxis Oncology has generated ($1.84) earnings per share over the last year (($1.84) diluted earnings per share). Earnings for Pyxis Oncology are expected to decrease in the coming year, from ($0.85) to ($1.30) per share. Pyxis Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Pyxis Oncology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/21/2024Q4 2023($0.49)($0.33)+$0.16($0.33)--11/7/2023Q3 2023($0.57)($0.56)+$0.01($0.56)--8/11/2023Q2 2023($0.65)($0.41)+$0.24($0.41)--5/11/2023Q1 2023($0.84)($0.54)+$0.30($0.54)--3/22/2023Q4 2022($0.85)($1.04)($0.19)($1.04)--11/1/2022Q3 2022($0.76)($0.85)($0.09)($0.85)-- Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q2 2022($0.68)($0.79)($0.11)($0.79)--5/13/2022Q1 2022($0.62)($0.97)($0.35)($0.97)--11/15/2021Q3 2021($0.53)($7.34)($6.81)($5.72)-- Pyxis Oncology Earnings - Frequently Asked Questions When is Pyxis Oncology's earnings date? Pyxis Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on PYXS's earnings history. Did Pyxis Oncology beat their earnings estimates last quarter? In the previous quarter, Pyxis Oncology (NASDAQ:PYXS) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.16. Learn more on analysts' earnings estimate vs. PYXS's actual earnings. How much profit does Pyxis Oncology generate each year? Pyxis Oncology (NASDAQ:PYXS) has a recorded net income of -$73.79 million. PYXS has generated -$1.84 earnings per share over the last four quarters. What is Pyxis Oncology's EPS forecast for next year? Pyxis Oncology's earnings are expected to decrease from ($0.85) per share to ($1.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies: KMDA Earnings URGN Earnings FHTX Earnings AVIR Earnings VSTM Earnings AQST Earnings VRCA Earnings VTYX Earnings AEON Earnings XOMA Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings call This page (NASDAQ:PYXS) was last updated on 4/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 1,000X Crypto PlaybookTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.